Chinese inhibitor drug candidate becomes first to enter phase
Chinese biotech company Jacobio Pharma announced on Monday that it had received approval from Chinese regulatory authorities for the registration phase-3 clinical trial of a combination therapy using its SHP2 inhibitor drug candidate JAB-3312.
SHP2 inhibitors are expected worldwide to have a substantial clinical effect in cancer and immunity disease treatment, and the approval made JAB-3312 the first SHP2 inhibitor to enter the phase-3 clinical study globally.
The approved clinical study in China is designed to evaluate the efficacy and safety of JAB-3312 in combination with the company's other investigational drug candidate KRAS G12C inhibitor glecirasib, for treating first-line non-small cell lung cancer patients with KRAS G12C mutations.
The control arm is the current standard treatment for first-line non-small cell lung cancer, which is the combination therapy of PD-1 antibody and chemotherapy.
Related articles
Is Charles' portrait a warning about the future of the monarchy?
King Charles' first portrait as a monarch has been unveiled, but experts have suggested that the art2024-05-18Togo's presidents signs a law expected to extend his decades
LOME, Togo (AP) — Togolese President Faure Gnassingbe has signed a controversial new constitution th2024-05-18The FAA investigates after Boeing says workers in South Carolina falsified 787 inspection records
SEATTLE (AP) — The Federal Aviation Administration said Monday it has opened an investigation into B2024-05-18Kaia Gerber flashes her bra in a sheer black mesh top with maxi coat as she heads out in New York
Kaia Gerber looked effortlessly chic in an-all black look as she was seen out and about in New York2024-05-18EA Sports College Football 25 comes out on July 19. Edwards, Ewers, Hunter are on standard cover
EA Sports revealed a release date of the College Football 25 video game on Thursday and a cover imag2024-05-18Beyonce puts on a cheeky display in bottom
Beyoncé put on a bold display in her latest jaw-dropping Instagram post on Sunday.The 42-year-old si2024-05-18
atest comment